Live feed08:00:00·1122dPRReleasevia QuantisnowEyenovia Announces FDA Approval of Mydcombi™, the First Ophthalmic Spray for Mydriasis, Which Also Leverages the Company's Proprietary Optejet® Device PlatformByQuantisnow·Wall Street's wire, on your screen.EYEN· Eyenovia Inc.Health Care
